ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC

NCT04172259 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoadjuvant Chemotherapy

Interventions

DRUG: Doxorubicin liposome
DRUG: Cyclophosphamide
DRUG: Trastuzumab
DRUG: Docetaxel
DRUG: Epirubicin
DRUG: Pertuzumab
DRUG: Paclitaxel
DRUG: Paclitaxel-albumin

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]